Market Leadership ZOLL Itamar is a prominent player in the US home sleep testing market, specializing in sleep apnea management integrated within cardiac care, positioning it as a key provider for healthcare facilities and sleep clinics seeking advanced digital health solutions.

Innovative Technology The company's recent launch of the Arrhythmia Detection algorithm for WatchPAT devices indicates a commitment to enhancing device capabilities and expanding into arrhythmia monitoring, opening opportunities for partnerships with hospitals and cardiology specialists.

Strategic Acquisition Acquired by ZOLL Medical for $538 million, Itamar Medical now benefits from expanded distribution channels and increased credibility, enabling sales teams to leverage ZOLL’s broader healthcare network to accelerate product adoption.

Growth Potential With an estimated revenue between $100 million and $250 million and recent product innovations, there is significant upside for expanding sales efforts among sleep centers, cardiology practices, and digital health providers seeking integrated sleep and cardiac care solutions.

Funding & Expansion Having secured $70 million in funding, Itamar is well-positioned to scale product development and expand market reach, providing opportunities for upselling and cross-selling additional digital health and diagnostic tools to existing clients.